Statistics for Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
Total visits
| views | |
|---|---|
| Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? | 11 |
Total visits per month
| views | |
|---|---|
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 5 |
| April 2024 | 0 |
| May 2024 | 0 |
Top country views
| views | |
|---|---|
| Turkey | 4 |
| Sweden | 3 |
| Iraq | 2 |
| Switzerland | 1 |
| Venezuela | 1 |
Top city views
| views | |
|---|---|
| Istanbul | 4 |
| Sundsvall | 3 |
| Basel | 1 |